Alcohol Reduction News Today

Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.

Wegovy and Ozempic, drugs commonly used for weight loss, may be used to treat alcohol addiction, researchers say. Studies on semaglutide, the ingredient in both drugs, are examining whether people who take the medication can reduce alcohol consumption and cravings to drink. One newly published study offers the first evidence that GLP-1 agonists can help people manage alcohol addiction.

<p>The first published evidence from humans that semaglutide specifically reduces the symptoms of Alcohol Use Disorder (AUD) has been published in <em>The Journal of Clinical Psychiatry.</em></p>

A research team from the University of Oklahoma and Oklahoma State University says it has published the first evidence that the drug semaglutide specifically reduces symptoms of alcohol use disorder.

Anecdotal reports first surfaced last summer that the obesity wonder drug - taken as a daily pill or injection - was curbing the taste for alcohol among those prescribed it for weight loss .

In previous research, Andrew Subica and his colleagues found exceptionally high rates of alcohol use disorder (or alcohol abuse) and alcohol-related harms among Pacific Islander young adults.

Scientists have begun investigating whether so-called miracle obesity drugs can be used to help treat conditions such as dementia and alcohol addiction.

Scientists have begun investigating whether so-called miracle obesity drugs can be used to help treat conditions such as dementia and alcohol addiction.

Investigating the Potential of Obesity Drugs for Treating Various Conditions LONDON — Scientists are exploring whether obesity drugs, known as "miracle

Scientists are now exploring the potential of popular obesity drugs to address conditions like dementia and alcohol addiction, following recent trials that demonstrated the drugs' effectiveness in treating severe health issues.